CLASSYS Inc. (KOSDAQ:214150)
South Korea · Delayed Price · Currency is KRW 43,800
-2,550 (-5.50%)
Aug 12, 2026, 3:30 PM KST
CLASSYS Market Cap
CLASSYS has a market cap or net worth of 2.86 trillion as of August 12, 2026. Its market cap has decreased by -27.07% in one year.
Market Cap
2.86T
Enterprise Value
2.82T
Revenue
346.88B
Ranking
n/a
PE Ratio
21.19
Stock Price
43,800.00
ChartMarket Cap Chart
Since December 13, 2017, CLASSYS's market cap has increased from 279.08B to 2.86T, an increase of 923.57%. That is a compound annual growth rate of 30.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 2.86T | -19.77% |
| Dec 30, 2025 | 3.56T | 14.07% |
| Dec 30, 2024 | 3.12T | 28.96% |
| Dec 28, 2023 | 2.42T | 104.22% |
| Dec 29, 2022 | 1.19T | -2.59% |
| Dec 30, 2021 | 1.22T | 22.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| L&C BIO Co.,LTD | 1.74T |
| SD Biosensor | 793.08B |
| T&L Co., Ltd. | 533.94B |
| BioNote | 495.84B |
| Samyang Biopharm | 346.14B |
| Vieworks | 224.07B |
| Dongbang Medical | 136.28B |
| Shinhung | 129.09B |